Therapeutics

151 trials 76 recruiting

Filter these 151 trials by phase, country and sponsor.

Open in Search →

A Phase I First-in-Human Dose Escalation Trial to Evaluate the Safety and Efficacy of ARI-HER2 (HER2BBz CAR-T Cells) in Patients with HER2Po… Not authorised

2025-521052-35-00 Patients with HER2Positive Advanced Breast Cancer 7
Filgotinib bridging in newly diagnosed rheumatoid arthritis patients (FAST RA trial); A pragmatic randomized controlled non-inferiority low … Pending

2024-517112-30-00 Rheumatoid arthritis 6
Adding oxygen to enhance antibiotic treatment of chronic lung infection Pending

2024-513197-22-02 Primary ciliary dyskinesia 3
Fludarabine exposure in patients undergoing Fludarabine based lymphodepletion prior to CAR-T cell therapy Pending

2025-524278-40-00 Patients undergoing Fludarabine based lymphodepletion p 6
The effect of Oxygen sUppleTion on vascular resistance and FLOW: the OUTFLOW study Pending

2024-516279-34-00 Pulmonary Hypertension 6
High versus low dose serratus anterior plane block after minimally invasive valve surgery Pending

2023-508719-22-00 Serratus anterior plane block after an aortic valve rep 6
Intraperitoneal irinotecan with concomitant FOLFOX and bevacizumab for patients with unresectable colorectal peritoneal metastases – a phase… Pending

2024-517152-34-00 Irresectable peritoneal metastases of colorectal cancer 4
Effectiveness of a preventive strategy for cytomegalovirus infection guided differently from a universal prophylactic strategy in kidney tra… Pending

2024-515925-27-00 CMV 5
Effect of Empagliflozin in patients with eGFR between 10 and 20 ml/min/1.73m2 - EMPA [10-20] Pending

2025-522119-41-00 Patients with renal impairment and type 2 diabetes. 5
Early optimization of ceftazidine dosing regimen in critical care : FORTOPTIM_1 Pending

2024-519783-41-00 sepsis 4
Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Cardiovascular disease 5
Vitamin D as add-on treatment option of pneumonia and sepsis in elderly subjects (TreatViD) Pending

2024-515978-27-00 Sepsis 11
MAGNEFFICIENT: A prospective, randomized, double-blind, placebo-controlled, single-center clinical trial. Pending

2025-522839-33-00 Postoperative Hypoparathyroidism after thyroid surgery. 5
Oxytocine and migraine Pending

2023-504690-21-00 This is a study in healthy volunteers. We will study t 3
CANDISHORT : A randomized study of a short duration therapy for candidemia Pending

2024-514244-81-00 Uncomplicated candidemia 5
ALLIC 2022 international clinical investigation for advanced management of childhood acute lymphoblastic leukemia Pending

2024-513824-41-00 Childhood non-mature-B Acute Lymphoblastic Leukemia 6
Botulinumtoxin type A for treatment of Chronic Pelvic Pain Syndrome (CPPS): a phase 3 randomized, double blind, placebo-controlled, multi-ce… Pending

2023-506372-27-00 Adult patients, male or female, with chronic pelvic pai 5
NEurotrophins MImetic compound for modulation of ischemia/reperfusion damage in Liver transplantation with Extended criteria Donors, a phase… Pending

2023-508977-10-00 Liver Transplant 9
The NIMBUS study: A study on inhalation therapy with liposomal amphotericin B and its distribution in the lungs in chronic pulmonary fungal … Pending

2025-521770-34-00 Chronic pulmonary aspergillosis 3
THE ROLE OF PANCREATIC STONE PROTEIN (PSP) AND PSP-GUIDED EARLY MEROPENEM TREATMENT TO MITIGATE SEPSIS RISK AT THE EMERGENCY DEPARTMENT: TH… Pending

2025-525006-37-00 Infection and sepsis 5
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients Pending

2023-504846-73-01 Glioblstoma WHO grade IV 4
SCARFREE-001: Verteporfin for Scar Prevention Pending

2025-525083-14-00 Scar formation following surgical wounds 4
CAT-VHL - Exploring the role of Carbonic Anhydrase IX as diagnostic and Theranostic target in Von-Hippel Lindau disease Pending

2024-515679-36-01 Von-Hippel Lindau (VHL) Disease 4
DIFFUSION CHARACTERISTICS OF LETIBOTULINUMTOXIN A IN COMPARISON TO ONA AND ABO-BONTA Pending

2024-511047-26-01 Stable health without uncontrolled systemic diseases; H 6